MOSS — Moss Genomics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$2.76m
- CA$2.30m
Annual cashflow statement for Moss Genomics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.001 | -0.108 | -0.655 | -0.73 | -0.133 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | 0.1 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.001 | 0.107 | 0.049 | -0.13 | 0.071 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0 | -0.002 | -0.568 | -0.715 | -0.036 |
| Capital Expenditures | — | — | -0.051 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.046 | 0 | — |
| Sale of Business | |||||
| Cash from Investing Activities | — | — | -0.005 | 0 | — |
| Financing Cash Flow Items | — | — | 0.308 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0.002 | 1.26 | 0.045 | 0.03 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0 | -0 | 0.687 | -0.67 | -0.006 |